| May 17, 2024 |
May 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF SCIENTIFIC OFFICER |
Sell |
42.5
|
-8,088
|
-9.99%
|
✗
|
$95.2K |
| Feb 17, 2024 |
Feb 21, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF SCIENTIFIC OFFICER |
Sell |
7.5
|
-28,288
|
-31.28%
|
✓
|
$397.9K |
| Feb 14, 2024 |
Feb 16, 2024 |
KalVista Pharmaceuticals, Inc.
|
CHIEF SCIENTIFIC OFFICER |
Sell |
40.0
|
-28,171
|
-28.22%
|
✗
|
$422.8K |
| Jan 11, 2024 |
Jan 12, 2024 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
7.5
|
-22,679
|
-36.28%
|
✓
|
$295.5K |
| Jan 8, 2024 |
Jan 10, 2024 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
15.0
|
-17,321
|
-21.70%
|
✓
|
$225.3K |
| Nov 17, 2023 |
Nov 21, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
46.3
|
-4,958
|
-5.85%
|
✗
|
$40.8K |
| Aug 17, 2023 |
Aug 21, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
42.5
|
-4,976
|
-6.36%
|
✗
|
$53.4K |
| May 17, 2023 |
May 19, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
46.3
|
-1,786
|
-2.61%
|
✗
|
$18.1K |
| Feb 17, 2023 |
Feb 23, 2023 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
46.3
|
-2,228
|
-3.35%
|
✗
|
$17.1K |
| Nov 17, 2022 |
Nov 21, 2022 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
50.0
|
-530
|
-0.84%
|
✗
|
$2.9K |
| Aug 17, 2022 |
Aug 19, 2022 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
50.0
|
-532
|
-0.86%
|
✗
|
$8K |
| Nov 1, 2021 |
Nov 3, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
10.0
|
-6,000
|
-72.87%
|
✓
|
$108.4K |
| Aug 2, 2021 |
Aug 4, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
10.0
|
-6,000
|
-42.15%
|
✓
|
$123.1K |
| Jun 1, 2021 |
Jun 3, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
7.5
|
-34,000
|
-70.49%
|
✓
|
$908.4K |
| May 3, 2021 |
May 7, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
25.0
|
-6,000
|
-11.06%
|
✓
|
$149.1K |
| May 3, 2021 |
May 6, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
28.8
|
-6,000
|
-9.96%
|
✓
|
$149.1K |
| Feb 23, 2021 |
Feb 25, 2021 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
5.0
|
-31,000
|
-36.37%
|
✓
|
$1M |
| Nov 2, 2020 |
Nov 4, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
28.8
|
-6,000
|
-7.62%
|
✓
|
$102.8K |
| Oct 20, 2020 |
Oct 22, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
17.5
|
-16,907
|
-17.68%
|
✓
|
$303K |
| Oct 16, 2020 |
Oct 20, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
48.8
|
-993
|
-1.03%
|
✓
|
$16.9K |
| Feb 5, 2020 |
Feb 7, 2020 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
55.0
|
-100
|
-0.10%
|
✓
|
$1.7K |
| Jul 22, 2019 |
Jul 24, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
37.5
|
-3,300
|
-3.30%
|
✓
|
$61.4K |
| Apr 17, 2019 |
Apr 18, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
37.5
|
-4,000
|
-3.84%
|
✓
|
$99.7K |
| Jan 16, 2019 |
Jan 18, 2019 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
37.5
|
-4,000
|
-3.70%
|
✓
|
$78.2K |
| Sep 18, 2018 |
Sep 20, 2018 |
KalVista Pharmaceuticals, Inc.
|
Chief Scientific Officer |
Sell |
91.3
|
+10,000
|
10.20%
|
✗
|
$42.6K |